Aseptic Processing for Cytotherapy, Regenerative Medicine, and Tissue-Engineered Products

Publication
Article
BioPharm InternationalBioPharm International-10-15-2015
Volume 2015 eBook
Issue 2

Isolators offer a safety and economic advantage for next-generation regenerative medicine products.

BioPharm International

eBooks Volume 28, Issue 14  

Manufacturing advanced biologics demands solutions that are quite different from what is being used for large-scale industrial biologics processing today. This article touches on approaches that work with advanced biologics.   Read this article and other articles in

BioPharm International

's 2015

The Future of Bioprocessing

eBook.

Articles in this issue
BP1015-Fluctuating.gif
Fluctuating Capacity and Demand Conditions in Biomanufacturing
BP1015-Cleaning.gif
Cleaning Validation for Biologics
BP1015-Automation.gif
Automation of Single-Use Systems
BP1015-Aseptic.gif
Aseptic Processing for Cytotherapy, Regenerative Medicine, and Tissue-Engineered Products
BP1015-Patent.gif
Are Biopharma Patents Poised on the Post-Grant Chopping Block?
BP1015-Innovations.gif
Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations
BP1015-Raising-the-bar.gif
Raising the Bar for Biopharma Training
Recent Videos
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content
Syringe and needle, sterile medicine equipment. medical equipment syringe needle. | Image Credit: © aapsky - stock.adobe.com

Simtra Completes Construction of New Production Facility in Germany

Patrick Lavery
July 1st 2025
Article

The new building will create 150 new jobs and expands total production area to nearly 12,000 square meters.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Darmstadt, Germany - November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. | Image Credit: © Anne Czichos - stock.adobe.com

Simtra, MilliporeSigma Align to Provide ADC Drug Substance, Drug Manufacturing Services

Patrick Lavery
June 11th 2025
Article

The agreement, which covers a period of five years, has been designed to offer a turnkey service to companies seeking faster time to market for ADCs and bioconjugates.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Abstract logo featuring a sleek, blue arrow curving around a circular element, suggesting growth and speed. Motion blur effect adds dynamism. | Image Credit: ©joeycheung – Stock.Adobe.com

The Challenges of Downstream Operations in the World of Continuous Biomanufacturing

Jeffery Odum
June 8th 2025
Article

A continuous biomanufacturing platform can process higher/lower quantities of a drug as needed and allow manufacturers to respond to changing markets.

A scientist in sterile coverall gown using a daily checklist check the cleanroom condition status in laboratory. Cleanroom facility. | Image Credit: ©warut – Stock.Adobe.com

Advances in Digitalization and Automation of Aseptic Processing

Cynthia A. Challener
June 7th 2025
Article

The increasing diversity and complexity of injectable drug products is driving innovation.

© 2025 MJH Life Sciences

All rights reserved.